CYP17 POLYMORPHISMS AND PROSTATE CANCER OUTCOMES

OBJECTIVE: Cytochrome P450 17α-hydroxylases-C-(17,20)-lyase (CYP17) is a key enzyme involved with the androgen biosynthesis pathway and has recently been targeted for therapy in men with advanced prostate cancer (PCa). However, studies relating prostate cancer outcomes with CYP17 gene variants have...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Wright, Jonathan L, Kwon, Erika M, Lin, Daniel W, Kolb, Suzanne, Koopmeiners, Joseph S, Feng, Ziding, Ostrander, Elaine A., Stanford, Janet L
Formato: Artigo
Idioma:Inglês
Publicado em: 2010
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2878282/
https://ncbi.nlm.nih.gov/pubmed/20503394
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pros.21143
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados